Implementing and Scaling Up HCV Treatment Services for People Who Inject Drugs and Other High Risk Groups in Ukraine: An Evaluation of Programmatic and Treatment Outcomes

BACKGROUND: HCV prevalence estimates among people who inject drugs (PWID) in Ukraine is high (60%-90%), yet barriers to HCV treatment and care remain substantial including limited access to direct acting antiviral (DAA) medications. A feasibility scale-up project implemented HCV treatment in communi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Drug Policy
Autori principali: Mazhnaya, Alyona, Meteliuk, Anna, Barnard, Tetiana, Zelenev, Alexei, Filippovych, Sergii, Altice, Frederick L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918282/
https://ncbi.nlm.nih.gov/pubmed/28811159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2017.07.023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi